Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum: Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report.
Sota Y, Einama T, Kobayashi K, Fujinuma I, Tsunenari T, Takihata Y, Iwasaki T, Miyata Y, Okamoto K, Kajiwara Y, Shinto E, Tsujimoto H, Yasuda S, Isozaki Y, Yamada S, Yamamoto J, Ueno H, Kishi Y. Sota Y, et al. Among authors: kobayashi k. Mol Clin Oncol. 2021 Jun;14(6):126. doi: 10.3892/mco.2021.2288. Epub 2021 Apr 26. Mol Clin Oncol. 2021. PMID: 33981430 Free PMC article.
A rare case of isolated splenic sarcoidosis: A case report and literature review.
Kobayashi K, Einama T, Fujinuma I, Tsunenari T, Miyata Y, Iwasaki T, Asakuma J, Soga S, Shinmoto H, Tsujimoto H, Hase K, Ueno H, Kishi Y. Kobayashi K, et al. Mol Clin Oncol. 2021 Feb;14(2):22. doi: 10.3892/mco.2020.2184. Epub 2020 Dec 3. Mol Clin Oncol. 2021. PMID: 33335730 Free PMC article.
Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma.
Takihata Y, Einama T, Kobayashi K, Suzuki T, Yonamine N, Fujinuma I, Tsunenari T, Yamagishi Y, Iwasaki T, Miyata Y, Shinto E, Ogata S, Tsujimoto H, Ueno H, Kishi Y. Takihata Y, et al. Among authors: kobayashi k. Oncol Lett. 2021 May;21(5):414. doi: 10.3892/ol.2021.12675. Epub 2021 Mar 23. Oncol Lett. 2021. PMID: 33841575 Free PMC article.
Clinical Impact of Dual Time Point 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer.
Einama T, Yamagishi Y, Takihata Y, Konno F, Kobayashi K, Yonamine N, Fujinuma I, Tsunenari T, Kouzu K, Nakazawa A, Iwasaki T, Shinto E, Ishida J, Ueno H, Kishi Y. Einama T, et al. Among authors: kobayashi k. Cancers (Basel). 2022 Jul 28;14(15):3688. doi: 10.3390/cancers14153688. Cancers (Basel). 2022. PMID: 35954351 Free PMC article.
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients.
Einama T, Yamagishi Y, Takihata Y, Suzuki T, Yamasaki T, Hirose Y, Kobayashi K, Yonamine N, Fujinuma I, Tsunenari T, Koga M, Ishibashi Y, Nagata K, Shiraishi T, Nakazawa A, Iwasaki T, Shinto E, Kato K, Sato K, Ueno H, Kishi Y, Tsuda H. Einama T, et al. Among authors: kobayashi k. Biomark Res. 2021 Oct 29;9(1):78. doi: 10.1186/s40364-021-00335-3. Biomark Res. 2021. PMID: 34715925 Free PMC article.
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial.
Uemura H, Matsushima H, Kobayashi K, Mizusawa H, Nishimatsu H, Fizazi K, Smith M, Shore N, Tammela T, Tabata KI, Matsubara N, Iinuma M, Uemura H, Oya M, Momma T, Kawakita M, Fukasawa S, Kobayashi T, Kuss I, Le Berre MA, Snapir A, Sarapohja T, Suzuki K. Uemura H, et al. Among authors: kobayashi k, kobayashi t. Int J Clin Oncol. 2021 Mar;26(3):578-590. doi: 10.1007/s10147-020-01824-5. Epub 2020 Nov 23. Int J Clin Oncol. 2021. PMID: 33226524 Free PMC article. Clinical Trial.
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.
Uemura H, Kobayashi K, Yokomizo A, Hinotsu S, Horie S, Kakehi Y, Nonomura N, Ogawa O, Oya M, Suzuki K, Saito A, Asakawa K, Uno S, Naito S. Uemura H, et al. Among authors: kobayashi k. Int J Clin Oncol. 2022 Oct;27(10):1632-1643. doi: 10.1007/s10147-022-02221-w. Epub 2022 Aug 10. Int J Clin Oncol. 2022. PMID: 35948732 Free PMC article.
Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N. Shindo T, et al. Among authors: kobayashi k. World J Urol. 2024 May 9;42(1):307. doi: 10.1007/s00345-024-04952-z. World J Urol. 2024. PMID: 38722418
11,754 results
You have reached the last available page of results. Please see the User Guide for more information.